Maulik Nanavaty Boston Scientific Corp (BSX) insider trading activity

Maulik Nanavaty is SVP & Pres, Neuromodulation of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 177,258 shares of BSX, which is worth approximately $13.6 Million. The most recent transaction as insider was on Feb 28, 2022, when has been sold 564 shares (Common Stock) at a price of $44.17 per share, resulting in proceeds of $24,912. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 177K

0% 3M change

0% 12M change

Total Value Held $13.6 Million

Maulik Nanavaty Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2022	SELL Payment of exercise price or tax liability	$24,912 $44.17 p/Share	564 Reduced 0.32%	177,258 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	1,630 Added 0.91%	177,822 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$25,232 $42.55 p/Share	593 Reduced 0.34%	176,192 Common Stock
Feb 21 2022	BUY Exercise of conversion of derivative security	-	1,714 Added 0.96%	176,785 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$26,211 $42.55 p/Share	616 Reduced 0.35%	175,071 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	1,779 Added 1.0%	175,687 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$32,123 $42.83 p/Share	750 Reduced 0.43%	173,908 Common Stock

Feb 17 2022	BUY Exercise of conversion of derivative security	-	2,166 Added 1.22%	174,658 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$25,306 $44.01 p/Share	575 Reduced 0.33%	172,492 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	1,661 Added 0.95%	173,067 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$99,658 $42.48 p/Share	2,346 Reduced 1.35%	171,406 Common Stock
Jan 01 2022	BUY Exercise of conversion of derivative security	-	6,175 Added 3.43%	173,752 Common Stock
May 28 2021	SELL Open market or private sale	$3,330,197 $42.59 p/Share	78,192 Reduced 31.91%	166,869 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$21,872 $38.78 p/Share	564 Reduced 0.23%	245,061 Common Stock
Feb 28 2021	BUY Exercise of conversion of derivative security	-	1,629 Added 0.66%	245,625 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$25,558 $39.2 p/Share	652 Reduced 0.27%	243,996 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	1,883 Added 0.76%	244,648 Common Stock
Feb 21 2021	SELL Payment of exercise price or tax liability	$22,552 $38.03 p/Share	593 Reduced 0.24%	242,765 Common Stock
Feb 21 2021	BUY Exercise of conversion of derivative security	-	1,713 Added 0.7%	243,358 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$23,075 $37.52 p/Share	615 Reduced 0.25%	241,645 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	1,778 Added 0.73%	242,260 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$22,074 $38.39 p/Share	575 Reduced 0.24%	240,482 Common Stock
Feb 15 2021	BUY Exercise of conversion of derivative security	-	1,661 Added 0.68%	241,057 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$87,024 $38.85 p/Share	2,240 Reduced 0.93%	239,396 Common Stock
Feb 10 2021	BUY Grant, award, or other acquisition	-	6,477 Added 2.61%	241,636 Common Stock

Also insider at

RANI

Rani Therapeutics Holdings, Inc. Healthcare

Maulik Nanavaty

SVP & Pres, Neuromodulation

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account